Needle-free insulin soon in India
Biotechnology company Shreya Lifesciences has entered into an in-licensing agreement with US-based Generex Biotechnology Corp to market Oral-lyn, the country
Say something
Tags: Biocon, biotechnology, Business Partnership, Business/Finance, Diabetes mellitus, Health/Medical/Pharmaceuticals, India, Inhalable insulin, inhaled insulin products, insulin, Insulin therapy, news, novo nordisk, Novo Nordisk A/S, oral, PFIZER INC., post manufacturing expenses, retail shops, Rs, Shreya Lifesciences, United States
-
-
Flipkart Health+ App Launched
06-04-2022
